ROLE OF HORMONE RECEPTORS AND HER2 IMMUNOHISTOCHEMISTRY IN PREDICTING RESPONSE TONEOADJUVANT CHEMOTHERAPY IN BREAST CANCER. IJARR [Internet]. 2016 Nov. 24 [cited 2026 Jul. 16];1(11):22-6. Available from: https://www.ijarr.org/index.php/ijarr/article/view/717